The Vanderbilt University

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Pain Management Smartphone Application for Patients With Stage III-IV Head and Neck Cancer Undergoing Radiation Therapy

Not Applicable

Completed

Conditions: Pain
Esophageal Cancer
Head and Neck Cancer
Lung Cancer

Interventions: Behavioral: Telephone-Based Intervention
Other: Questionnaire Administration

First Posted Date: 2014-12-24

Last Posted Date: 2016-07-13

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 24

Registration Number: NCT02324881

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Trametinib in Treating Patients With Advanced Melanoma With BRAF Non-V600 Mutations

Phase 2

Completed

Conditions: Recurrent Melanoma
Stage IIIB Melanoma
Stage IIIC Melanoma
Stage IV Melanoma

Interventions: Drug: trametinib
Other: laboratory biomarker analysis
Other: pharmacological study

First Posted Date: 2014-11-20

Last Posted Date: 2021-05-28

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 9

Registration Number: NCT02296112

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

and more 1 locations

Quantitative MRI in Assessing Disease in Patients With Brain Tumors

Not Applicable

Terminated

Conditions: Tumors Metastatic to Brain
Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Procedure: diffusion-weighted magnetic resonance imaging
Procedure: chemical exchange saturation transfer magnetic resonance imaging
Procedure: dynamic contrast-enhanced magnetic resonance imaging
Procedure: dynamic susceptibility contrast-enhanced magnetic resonance imaging

First Posted Date: 2014-10-20

Last Posted Date: 2018-05-29

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 10

Registration Number: NCT02269111

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell Transplant

Not Applicable

Terminated

Conditions: Diabetes Mellitus
Malignant Neoplasm

Interventions: Procedure: assessment of therapy complications
Other: laboratory biomarker analysis

First Posted Date: 2014-09-15

Last Posted Date: 2019-07-18

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 22

Registration Number: NCT02240381

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

FDG-PET in Advanced Melanoma

Not Applicable

Terminated

Conditions: Stage IV Melanoma
Stage IIIA Melanoma
Stage IIIB Melanoma
Stage IIIC Melanoma
Recurrent Melanoma

Interventions: Diagnostic Test: [18F]fluorodeoxyglucose
Other: Molecular assays on biopsied tissue
Device: positron emission tomography
Device: computed tomography

First Posted Date: 2014-09-10

Last Posted Date: 2017-04-13

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 3

Registration Number: NCT02236546

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Home-Based Lymphedema Care Program (HBLCP) in Improving Lymphedema Self-Care in Head and Neck Cancer Survivors

Not Applicable

Terminated

Conditions: Head and Neck Cancer
Lymphedema

Interventions: Behavioral: Home-based Lymphedema Care Program

First Posted Date: 2014-06-23

Last Posted Date: 2018-01-25

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 20

Registration Number: NCT02170272

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Prospective Outcomes of Second-Line Therapy in Acute Graft-Versus-Host Study Including ECP (POSTAGE)

Terminated

Conditions: Graft Versus Host Disease

Interventions: Other: medical chart review
Other: quality-of-life assessment

First Posted Date: 2014-05-30

Last Posted Date: 2019-10-17

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 19

Registration Number: NCT02151539

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇩🇪
Klinikum der Universität Regensburg, Regensburg, Germany
🇬🇧
Nottingham City Hospital, Nottingham, United Kingdom

and more 4 locations

Programs to Support You During Chemotherapy (Pro-You)

Not Applicable

Completed

Conditions: Depressive Symptoms
Psychosocial Effects of Cancer and Its Treatment
Stage IIIA Rectal Cancer
Stage IVA Rectal Cancer
Fatigue
Stage IIA Rectal Cancer
Stage IIA Colon Cancer
Stage IIB Colon Cancer
Stage IIB Rectal Cancer
Stage IIC Colon Cancer

Interventions: Behavioral: Yoga Skills Training (YST)
Other: questionnaire administration
Other: psychological stress assessment
Other: fatigue and depressive symptom assessment and management
Other: laboratory biomarker analysis
Other: Attention Control

First Posted Date: 2014-05-28

Last Posted Date: 2015-06-23

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 3

Registration Number: NCT02148406

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

3-Tesla MRI Response to TACE in HCC (Liver Cancer)

Not Applicable

Terminated

Conditions: Advanced Adult Primary Liver Cancer
Adult Primary Hepatocellular Carcinoma
Localized Resectable Adult Primary Liver Cancer
Localized Unresectable Adult Primary Liver Cancer
Stage A Adult Primary Liver Cancer (BCLC)
Stage B Adult Primary Liver Cancer (BCLC)

Interventions: Device: 3 Tesla Magnetic Resonance Imaging
Drug: Magnevist® (Intravenous (IV) administration of MRI contrast agent)

First Posted Date: 2014-02-07

Last Posted Date: 2018-07-11

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 2

Registration Number: NCT02057874

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

3T MRI Biomarkers of Glioma Treatment Response

Early Phase 1

Terminated

Conditions: Adult Anaplastic Ependymoma
Adult Gliosarcoma
Adult Anaplastic Astrocytoma
Adult Giant Cell Glioblastoma
Adult Glioblastoma
Adult Anaplastic Oligodendroglioma
Recurrent Adult Brain Tumor

Interventions: Device: 3-Tesla magnetic resonance imaging
Device: CEST-MRI
Device: DW-MRI
Device: DCE-MRI
Device: DSC-MRI
Drug: IV administration of gadolinium-containing contrast agent

First Posted Date: 2013-11-27

Last Posted Date: 2017-04-17

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 7

Registration Number: NCT01996527

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy